• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白与初始冠状动脉形态联合预测川崎病冠状动脉病变的持续存在。

Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease.

机构信息

Pediatric Emergency Unit, Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria, Polyclinic of St.Orsola, University of Bologna, 40138, Bologna, Italy.

Specialty School of Paediatrics, Alma Mater Studiorum, University of Bologna, 40138, Bologna, Italy.

出版信息

Sci Rep. 2022 May 23;12(1):8640. doi: 10.1038/s41598-022-12702-7.

DOI:10.1038/s41598-022-12702-7
PMID:35606405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9127106/
Abstract

Kawasaki Disease (KD) is systemic vasculitis involving medium-sized vessels in children. The aim of our study is to determine if fecal calprotectin (FC) could be useful in predicting the development or persistence of coronary artery lesions (CALs) in KD. We conducted a prospective monocentric study including all consecutive diagnoses of. Clinical, laboratory, echocardiographic data were recorded during the acute and subacute phase, including FC. Correlations among laboratory values, FC, clinical manifestations, IVIG-responsiveness and CALs development were investigated. We enrolled 26 children (76.9% boys; median age 34.5 months). The combination of FC > 250 microg/g and z-score > 2 during the acute phase was associated with the persistence of CALs (p = 0.022). A z-score > 2 alone during the acute phase was not related to CALs during the subacute stage (p > 0.05). A neutrophil percentage > 70% and WBC > 15,000/mmc during the acute phase significantly correlated with the presence of CALs during the subacute phase (p = 0.008). C-reactive protein (CRP) > 13 mg/dL at KD onset was significantly associated with the presence of CALs during the acute (p = 0.017) and subacute phase (p = 0.001). The combination of FC > 250 microg/g and a z-score > 2 during the acute phase of KD may be used as a predictor of CALs persistence. It can be useful especially in children with an initial CRP < 13 mg/dl.

摘要

川崎病(KD)是一种累及儿童中型血管的全身性血管炎。我们的研究目的是确定粪便钙卫蛋白(FC)是否可用于预测 KD 中冠状动脉损伤(CALs)的发展或持续存在。我们进行了一项前瞻性单中心研究,纳入了所有连续诊断为 KD 的患者。在急性期和亚急性期记录临床、实验室和超声心动图数据,包括 FC。研究了实验室值、FC、临床表现、IVIG 反应性和 CALs 发展之间的相关性。我们共纳入 26 例患儿(76.9%为男性;中位年龄 34.5 个月)。急性期 FC>250μg/g 和 z 评分>2 的联合与 CALs 的持续存在相关(p=0.022)。急性期单独的 z 评分>2 与亚急性期的 CALs 无关(p>0.05)。急性期中性粒细胞百分比>70%和 WBC>15,000/mmc 与亚急性期 CALs 的存在显著相关(p=0.008)。KD 发病时 CRP>13mg/dL 与急性期(p=0.017)和亚急性期(p=0.001)CALs 的存在显著相关。KD 急性期 FC>250μg/g 和 z 评分>2 的联合可作为 CALs 持续存在的预测指标。在 CRP<13mg/dL 的患儿中,该方法可能尤其有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f8/9127106/ae770f532d6f/41598_2022_12702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f8/9127106/754f56dffd97/41598_2022_12702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f8/9127106/ae770f532d6f/41598_2022_12702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f8/9127106/754f56dffd97/41598_2022_12702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f8/9127106/ae770f532d6f/41598_2022_12702_Fig2_HTML.jpg

相似文献

1
Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease.粪便钙卫蛋白与初始冠状动脉形态联合预测川崎病冠状动脉病变的持续存在。
Sci Rep. 2022 May 23;12(1):8640. doi: 10.1038/s41598-022-12702-7.
2
The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.血清脂质在预测川崎病冠状动脉病变和静脉注射免疫球蛋白抵抗中的作用:一项队列研究。
J Int Med Res. 2024 May;52(5):3000605241252115. doi: 10.1177/03000605241252115.
3
Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.单核细胞/高密度脂蛋白胆固醇比值对川崎病冠状动脉病变及静脉用免疫球蛋白抵抗的预测价值。
Eur J Pediatr. 2023 Oct;182(10):4399-4406. doi: 10.1007/s00431-023-05122-w. Epub 2023 Jul 22.
4
Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.基于 C 反应蛋白水平预测川崎病患儿冠状动脉病变:一项回顾性队列研究。
J Pediatr (Rio J). 2023 Jul-Aug;99(4):406-412. doi: 10.1016/j.jped.2023.02.005. Epub 2023 Mar 25.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.一项前瞻性研究比较了川崎病患者血清 IL6 和 CRP 水平与冠状动脉变化和治疗反应的关系。
Rheumatol Int. 2019 Oct;39(10):1797-1801. doi: 10.1007/s00296-019-04375-9. Epub 2019 Jul 13.
7
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白(IVIG)与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较:双治疗更有效吗?
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
8
Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.白介素-18 与川崎病患者冠状动脉病变。
J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.
9
Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.循环内皮糖萼成分作为川崎病冠状动脉病变的预测标志物。
Int J Cardiol. 2019 Oct 1;292:236-240. doi: 10.1016/j.ijcard.2019.05.045. Epub 2019 May 22.
10
Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.川崎病冠状动脉病变相关危险因素的临床意义。
Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11.

本文引用的文献

1
Kawasaki disease: pathophysiology and insights from mouse models.川崎病:病理生理学和来自小鼠模型的见解。
Nat Rev Rheumatol. 2020 Jul;16(7):391-405. doi: 10.1038/s41584-020-0426-0. Epub 2020 May 26.
2
Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation.肠通透性和 IgA 引发与心血管炎症相关的免疫血管炎。
Immunity. 2019 Sep 17;51(3):508-521.e6. doi: 10.1016/j.immuni.2019.05.021. Epub 2019 Aug 27.
3
Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease.
新诊断为炎症性肠病患者达到目标钙卫蛋白水平的时间。
J Pediatr Gastroenterol Nutr. 2019 Oct;69(4):466-473. doi: 10.1097/MPG.0000000000002458.
4
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.北美人群川崎病冠状动脉瘤风险模型的建立与验证。
J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.
5
Clinical value of fecal calprotectin.粪便钙卫蛋白的临床价值。
Crit Rev Clin Lab Sci. 2019 Aug;56(5):307-320. doi: 10.1080/10408363.2019.1619159. Epub 2019 Jun 6.
6
Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease.川崎病后巨大动脉瘤患儿及成人循环炎症标志物持续存在。
Circ Genom Precis Med. 2019 Apr;12(4):e002433. doi: 10.1161/CIRCGEN.118.002433. Epub 2019 Mar 7.
7
Systemic calprotectin and chronic inflammatory rheumatic diseases.系统钙卫蛋白与慢性炎症性风湿性疾病。
Joint Bone Spine. 2019 Nov;86(6):691-698. doi: 10.1016/j.jbspin.2019.01.003. Epub 2019 Jan 17.
8
Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.亚洲风险评分系统无法预测意大利队列川崎病患者静脉注射免疫球蛋白耐药和冠状动脉病变。
Eur J Pediatr. 2019 Mar;178(3):315-322. doi: 10.1007/s00431-018-3297-5. Epub 2018 Nov 29.
9
Autoimmune Aspects of Kawasaki Disease.川崎病的自身免疫方面。
J Investig Allergol Clin Immunol. 2019;29(4):251-261. doi: 10.18176/jiaci.0300. Epub 2018 Sep 5.
10
Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?川崎病的胃肠道表现:严重疾病的危险信号?
PLoS One. 2018 Sep 4;13(9):e0202658. doi: 10.1371/journal.pone.0202658. eCollection 2018.